Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1]
Perrillo RP..
The role of liver biopsy in hepatitis C..
Hepatology. , 26 (1997), pp. 57S-61S
[2]
Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K..
The role of liver biopsy in chronic hepatitis C..
Hepatology. , 33 (2001), pp. 196-200
[3]
Poynard T, Bedossa P..
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups..
J Viral Hepat. , 4 (1997), pp. 199-208
[4]
Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, et al..
Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C..
Hepatology. , 41 (2005), pp. 1376-82
[5]
Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T..
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study..
Lancet. , 357 (2001), pp. 1069-75
[6]
Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al..
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model..
Hepatology. , 36 (2002), pp. 986-92
[7]
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al..
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C..
Hepatology. , 38 (2003), pp. 518-26
[8]
Sud A, Hui JM, Farrell GC, Bandara P, Kench JG, Fung C, et al..
Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index..
Hepatology. , 39 (2004), pp. 1239-47
[9]
Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al..
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort..
Hepatology. , 42 (2005), pp. 282-92
[10]
Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al..
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection..
Hepatology. , 43 (2006), pp. 1317-25
[11]
Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, et al..
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C..
J Hepatology. , 44 (2006), pp. 686-93
[12]
Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, et al..
Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C..
J Hepatology. , 46 (2007), pp. 775-82
[13]
Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J..
Diagnostic accuracy of hyaluronan and type III procollagen amino terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis..
Clinical Chemistry. , 42 (1996), pp. 558-63
[14]
McHutchison JG, Blatt LM, De Medina M, Craig JR, Conrad A, Schiff ER, et al..
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology..
J Gastroenterol Hepatol. , 15 (2000), pp. 945-51
[15]
Rosenberg WMC, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, et al..
Serum markers detect the presence of liver fibrosis: A cohort study..
Gastroenterology. , 127 (2004), pp. 1704-13
[16]
Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al..
Transient elastography: A new noninvasive method for assessment of hepatic fibrosis..
Ultrasound in Medicine and Biology. , 29 (2003), pp. 1705-13
[17]
Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, Ter Beek LC, et al..
Liver fibrosis: non-invasive assessment with MR elastography..
Nmr in Biomedicine. , 19 (2006), pp. 173-9
[18]
Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al..
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C..
Hepatology. , 41 (2005), pp. 48-54
[19]
Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al..
Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C..
Gastroenterology. , 128 (2005), pp. 343-50
[20]
Martinez SM, Dominguez M, Fernandez-Varo G, Gonzalez P, Bataller R, Sampson E, et al..
Performance of non-invasive methods in the assessment of disease severity in routine clinical practice in patients with chronic hepatitis C..
Hepatology. , 46 (2007), pp. 318A-319A
[21]
Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al..
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease..
Gut. , 56 (2007), pp. 968-73
[22]
Lucidarme D, Foucher J, Le Bail B, Costera L, Villars S, Forzy G, et al..
The ratio interquartile range/median value of liver stiffness measurement is a key factor of accuracy of transient elastography (FibroScan (R)) for the diagnosis of liver fibrosis..
Hepatology. , 46 (2007), pp. 318A
[23]
Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, et al..
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases..
J Viral Hepatitis. , 14 (2007), pp. 360-9
[24]
Hirata M, Akbar SMF, Horiike N, Onji M..
Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus..
European J Clinic Investigation. , 31 (2001), pp. 528-35
[25]
Lewin M, Poujol-Robert A, Boelle PY, Wendum D, Lasnier E, Viallon M, et al..
Diffusion-weighted magnetic resonance Imaging for the assessment of fibrosis in chronic hepatitis C..
Hepatology. , 46 (2007), pp. 658-65
[26]
Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB..
Liver fibrosis: Noninvasive diagnosis with double contrast material-enhanced MR imaging..
Radiology. , 239 (2006), pp. 425-37
[27]
Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, et al..
Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index..
Radiology. , 245 (2007), pp. 458-66
[28]
Vanleeuwen DJ, Howe SC, Scheuer PJ, Sherlock S..
Portal-Hypertension in Chronic Hepatitis - Relationship to Morphological-Changes..
Gut. , 31 (1990), pp. 339-43
[29]
Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al..
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis..
N Engl J Med. , 353 (2005), pp. 2254-61
[30]
Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al..
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis..
Gastroenterology. , 133 (2007), pp. 481-8
[31]
Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia Pagan JC, et al..
Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure..
Gastroenterology. , 111 (1996), pp. 1018-22
[32]
DAmico G, Garcia-Pagan JC, Luca A, Bosch J..
Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: A systematic review..
Gastroenterology. , 131 (2006), pp. 1611-24
[33]
Groszmann RJ, Bosch J, Grace ND, Conn HO, Garciatsao G, Navasa M, et al..
Hemodynamic Events in A Prospective Randomized Trial of Propranolol Versus Placebo in the Prevention of A 1St Variceal Hemorrhage..
Gastroenterology. , 99 (1990), pp. 1401-7
[34]
Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al..
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis..
Hepatology. , 32 (2000), pp. 930-4
[35]
Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J..
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis..
Hepatology. , 37 (2003), pp. 902-8
[36]
Rincon D, Ripoll C, Lo Iacono O, Salcedo M, Catalina MV, Alvarez E, et al..
Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis..
Am J Gastroenterol. , 101 (2006), pp. 2269-74
[37]
Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al..
Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis..
Gut. , 52 (2003), pp. 1200-5
[38]
Taourel P, Blanc P, Dauzat M, Chabre M, Pradel J, Gallix B, et al..
Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: Relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure..
Hepatology. , 28 (1998), pp. 932-6
[39]
Schepke M, Raab P, Hoppe A, Schiedermaier P, Brensing KA, Sauerbruch T..
Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis..
Am J Gastroenterol. , 95 (2000), pp. 2905-9
[40]
Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al..
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis..
Hepatology. , 45 (2007), pp. 1290-7
[41]
Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, et al..
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C..
J Hepatol. , 41 (2004), pp. 830-6
[42]
Blasco A, Forns X, Carrion JA, Garcia-Pagan JC, Gilbert R, Rimola A, et al..
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation..
Hepatology. , 43 (2006), pp. 492-9
[43]
Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, et al..
Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis..
Liver Transplantation. , 13 (2007), pp. 1305-11
[44]
Carrion JA, Navasa M, Garcia-Retortillo M, Garcia-Pagan JC, Crespo G, Bruguera M, et al..
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: A randomized controlled study..
Gastroenterology. , 132 (2007), pp. 1746-56
[45]
Benlloch S, Berenguer M, Prieto M, Rayon JM, Aguilera V, Berenguer J..
Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index..
Liver Transplantation. , 11 (2005), pp. 456-62
[46]
Cisneros L, Londono MC, Blasco C, Bataller R, Miquel R, Bruguera M, et al..
Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C..
Liver Transplantation. , 13 (2007), pp. 1017-27
[47]
Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X..
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation..
Liver Transplantation. , 12 (2006), pp. 1791-8
